An In-Depth Understanding of OECD's TP Guidelines

This comprehensive course features engaging lectures on the OECD Transfer Pricing (TP) Guidelines, along with an interactive exercise tailored to deepen your knowledge of transfer pricing and intangible property transfers specifically within the pharmaceutical sector.

Course Highlights:

Real-World Scenario

Explore a detailed case study involving a multinational pharmaceutical group, encompassing various business activities such as research and development (R&D) services, the transfer and use of intangibles, manufacturing services, distribution companies, and financing arrangements provided by group entities.

Self-Learning Questions

The exercise includes targeted questions that enable learners to grasp the intricacies of the OECD Transfer Pricing Guidelines. Dive into the landmark case of GlaxoSmithKline Holdings (Americas) Inc. v. Commissioner of Internal Revenue, a significant transfer pricing dispute in the pharmaceutical industry.

Key Topics Covered

Gain insights into essential principles and methods outlined in the OECD Transfer Pricing Guidelines for allocating costs and profits related to intangible property transfers. Understand the documentation and compliance requirements necessary for effective transfer pricing, as well as the risks and challenges faced by multinational corporations.

Learning Objectives:

• Develop a comprehensive understanding of transfer pricing issues encountered by multinational pharmaceutical groups.

• Acquire the knowledge and skills required to implement effective transfer pricing policies.

• Ensure compliance with relevant regulations and guidelines while mitigating potential risks and challenges.

This practice test is meticulously designed to empower learners with proficiency in transfer pricing and intangible property transfers within the pharmaceutical industry. Join us to enhance your expertise and navigate the complexities of transfer pricing with confidence!